營養基因組學市場規模、佔有率和成長分析：按產品、按技術、按應用、按最終用途、按地區 - 行業預測，2024-2031 年

2022年全球營養基因組學市場規模將為3.862億美元，從2023年的4.5379億美元成長到2031年的16.4874億美元，預計在預測期內（2024-2031年）將以17.50的複合年成長率成長。

未來幾年，全球營養基因組學市場預計將成長，主要是由於慢性病盛行率上升。過去十年中蛋白質組學、基因組學和代謝體學的進步顯著提高了我們透過分析蛋白質途徑來識別疾病的能力，特別是在糖尿病、癌症和肥胖等受飲食選擇影響的疾病中。營養基因組學探討食品和基因表現之間的相互作用，深入了解不同的飲食成分如何改變個體的基因譜。然而，他們也面臨著有關基因研究和測試的政府法規的挑戰，這些法規阻礙了營養基因組學產品和服務的市場開拓。聯邦、州或地方政府實施的更嚴格的法律可能會使基因檢測變得更加繁重，並影響其在臨床管理和研究中的採用。使情況更加複雜的是，各地區與直接面對消費者的測試（DTC）相關的法律存在巨大差異，這為涉足營養基因組學的公司造成了重大障礙。因此，雖然市場擴張潛力巨大，但對於旨在向消費者提供創新營養基因組學測試解決方案的公司來說，監管障礙預計將是需要考慮的關鍵因素。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特分析與影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 技術進步
• 監管環境
• 案例研究分析
• PESTEL分析
• 市場吸引力指數
• 價格分析

全球營養基因體學市場規模：依產品分類的複合年成長率（2024-2031）

• 市場概況
• 試劑/套件
• 服務

全球營養基因體學市場規模：依技術分類的複合年成長率（2024-2031）

• 市場概況
• 唾液
• 頰黏膜拭子
• 血

全球營養基因組學市場規模：按應用/複合年成長率（2024-2031）

• 市場概況
• 肥胖
• 心血管疾病
• 癌症研究
• 其他

全球營養基因體學市場規模：依最終用途分類的複合年成長率（2024-2031）

• 市場概況
• 醫院/診所
• 網路平台
• 其他

全球營養基因體學市場規模/複合年成長率（2024-2031）

• 北美（產品、技術、應用、最終用途）
  • 美國
  • 加拿大
• 歐洲（產品、技術、應用、最終用途）
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區（產品、技術、應用、最終用途）
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲（產品、技術、應用、最終用途）
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲（產品、技術、應用、最終用途）
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Nutrigenomix
• The Gene Box
• Metagenics
• Xcode Life
• GX Sciences, LLC（Fagron）
• Cura Integrative Medicine
• DNAlife
• Genova Diagnostics（GDX）
• Holistic Health International, Llc
• Vitagene
• Mapmygenome
• GeneOmbio
• 23andMe Inc.
• DNAfit
• GX Sciences Inc.
• Amway
• Herbalife Nutrition Ltd.
• DSM Nutritional Products
• Syngene International

結論和建議

Global Nutrigenomics Market size was valued at USD 386.20 million in 2022 and is poised to grow from USD 453.79 million in 2023 to USD 1648.74 million by 2031, growing at a CAGR of 17.50% during the forecast period (2024-2031).

In the coming years, the global nutrigenomics market is poised for growth, largely driven by the rising prevalence of chronic illnesses. The advancements in proteomics, genomics, and metabolomics over the past decade have significantly enhanced the ability to identify diseases by analyzing protein pathways, especially in conditions like diabetes, cancer, and obesity, which are influenced by dietary choices. Nutrigenomics explores the interplay between food and gene expression, offering insights into how various dietary components can modify an individual's genetic profile. However, the market faces challenges from government regulations surrounding genetic research and testing, which can hamper the development of nutrigenomics products and services. Stricter laws imposed by federal, state, or local authorities can make genetic testing more cumbersome, affecting its adoption in clinical management and research. Additionally, the inconsistency of legislation related to direct-to-consumer (DTC) testing in different regions further complicates the landscape, creating a significant barrier for companies engaged in nutrigenomics. As a result, while there is substantial potential for market expansion, regulatory hurdles will be an important factor to consider for businesses aiming to innovate and bring nutrigenomics testing solutions to consumers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nutrigenomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nutrigenomics Market Segmental Analysis

Global Nutrigenomics Market is segmented into Product, Technique, Application, End Use, and region. By Product, the market is classified into Reagents & Kits, and Services. Depending on the Technique, it is categorized into Saliva, Buccal Swab, Blood. According to Application, the market is divided into Obesity, Cardiovascular Diseases, Cancer Research, Other. Based on End Use, the market is segmented into Hospitals & Clinics, Online Platforms, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Nutrigenomics Market

The global nutrigenomics market is witnessing significant growth driven by the escalating prevalence of chronic diseases, such as obesity, diabetes, and cardiovascular conditions. As these health issues become more prevalent, there is a growing demand for personalized nutrition that takes individual genetic factors into account. This customization of dietary approaches not only aids in the prevention and management of these ailments but also stimulates increased investments in tailored nutrition strategies. Consequently, the focus on nutrigenomics, which integrates genetic insights into dietary planning, is propelling market expansion and offering innovative solutions for better health outcomes globally.

Restraints in the Global Nutrigenomics Market

The global nutrigenomics market encounters significant challenges due to limited scientific evidence supporting the effectiveness of personalized nutrition interventions. While research in this area has shown potential, there remains a lack of extensive clinical validation and large-scale studies that demonstrate the long-term benefits of these solutions. Consequently, this uncertainty leads to skepticism among health care professionals and hesitance among consumers, ultimately impacting the overall acceptability and adoption of nutrigenomic solutions. The absence of robust data to substantiate claims about personalized nutrition hampers the market's growth and poses a considerable restraint on its development on a global scale.

Market Trends of the Global Nutrigenomics Market

The global nutrigenomics market is experiencing a significant trend towards personalized nutrition, driven by advancements in genetic testing and data analytics. Consumers are increasingly seeking tailored dietary solutions that align with their unique genetic profiles, which results in optimized health outcomes and preventive care. This surge is further amplified by the growing awareness of the relationship between genes, diet, and health, alongside increasing consumer demand for personalized health interventions. As companies innovate to offer customized nutritional plans, the market is poised for robust growth, with a wide range of applications in personal health management, chronic disease prevention, and overall wellness enhancement.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Case Study Analysis
• PESTEL Analysis
• Market Attractiveness Index
• Pricing Analysis

Global Nutrigenomics Market Size by Product & CAGR (2024-2031)

• Market Overview
• Reagents & Kits
• Services

Global Nutrigenomics Market Size by Technique & CAGR (2024-2031)

• Market Overview
• Saliva
• Buccal Swab
• Blood

Global Nutrigenomics Market Size by Application & CAGR (2024-2031)

• Market Overview
• Obesity
• Cardiovascular Diseases
• Cancer Research
• Others

Global Nutrigenomics Market Size by End Use & CAGR (2024-2031)

• Market Overview
• Hospitals & Clinics
• Online Platforms
• Others

Global Nutrigenomics Market Size & CAGR (2024-2031)

• North America, (Product, Technique, Application, End Use)
  • US
  • Canada
• Europe, (Product, Technique, Application, End Use)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product, Technique, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product, Technique, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product, Technique, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Nutrigenomix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Gene Box
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metagenics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xcode Life
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GX Sciences, LLC (Fagron)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cura Integrative Medicine
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNAlife
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genova Diagnostics (GDX)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Holistic Health International, Llc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitagene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mapmygenome
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneOmbio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 23andMe Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNAfit
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GX Sciences Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amway
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Herbalife Nutrition Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM Nutritional Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syngene International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation